Literature DB >> 26932309

The Use of a Brochure to Enable CAM-with-Chemotherapy Patient Education.

Peter J Smith1,2, Alexandra M Clavarino3, Jeremy E Long4, Kathryn J Steadman3.   

Abstract

The majority of cancer patients receiving chemotherapy will consider taking complementary and alternative medicine (CAM) during their treatment. As biologically-active CAM may detrimentally interfere with chemotherapy treatment, cancer patients require evidence-based information on chemotherapy-CAM integration consequences. This study aimed to assess if the availability of a purpose-designed brochure within a cancer service aided doctors' discussions with their patients on CAM use and helped patients understand the effects of CAM during their chemotherapy treatment. Cancer care doctors consulting in an adult day unit completed a structured post-intervention feedback survey form (n = 17), and cancer patients receiving chemotherapy treatment were provided the brochure and completed the local health service consumer testing feedback form (n = 30). All cancer care doctors perceived a need for the brochure and recommended the brochure to their patients. All doctors thought the brochure made it easier for them to discuss CAM with their patients, and 59 % believed that it saved them time during patient consultations. Ninety percent of cancer patients reported the brochure had enough information to answer their CAM questions, and all patients thought the information was easy to read and understand. An evidence-based CAM-with-chemotherapy patient brochure was perceived to have enabled cancer care doctors to discuss CAM with their patients and to have answered patients' CAM questions.

Entities:  

Keywords:  Chemotherapy; Complementary and alternative medicine; Patient education

Mesh:

Year:  2017        PMID: 26932309     DOI: 10.1007/s13187-016-1011-8

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  23 in total

Review 1.  Complementary and alternative medicine during cancer treatment: beyond innocence.

Authors:  Metin Tascilar; Floris A de Jong; Jaap Verweij; Ron H J Mathijssen
Journal:  Oncologist       Date:  2006 Jul-Aug

Review 2.  Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?

Authors:  Brian D Lawenda; Kara M Kelly; Elena J Ladas; Stephen M Sagar; Andrew Vickers; Jeffrey B Blumberg
Journal:  J Natl Cancer Inst       Date:  2008-05-27       Impact factor: 13.506

3.  Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy.

Authors:  Rachel A Murphy; Marina Mourtzakis; Quincy S C Chu; Vickie E Baracos; Tony Reiman; Vera C Mazurak
Journal:  Cancer       Date:  2011-02-28       Impact factor: 6.860

4.  Gaining insight into the what, why and where of complementary and alternative medicine use by cancer patients and survivors.

Authors:  N Humpel; S C Jones
Journal:  Eur J Cancer Care (Engl)       Date:  2006-09       Impact factor: 2.520

5.  A cautionary tale for probiotic use in hematopoietic SCT patients-Lactobacillus acidophilus sepsis in a patient with mantle cell lymphoma undergoing hematopoietic SCT.

Authors:  A Mehta; S Rangarajan; U Borate
Journal:  Bone Marrow Transplant       Date:  2012-08-13       Impact factor: 5.483

6.  Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.

Authors:  M A Richardson; T Sanders; J L Palmer; A Greisinger; S E Singletary
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

7.  Trick or treat? Australian newspaper portrayal of complementary and alternative medicine for the treatment of cancer.

Authors:  Reegan Mercurio; Jaklin Ardath Eliott
Journal:  Support Care Cancer       Date:  2009-11-27       Impact factor: 3.603

Review 8.  The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies.

Authors:  Nico J Diederich; Christopher G Goetz
Journal:  Neurology       Date:  2008-08-26       Impact factor: 9.910

9.  Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea.

Authors:  Bret Bannerman; Ling Xu; Matthew Jones; Christopher Tsu; Jie Yu; Paul Hales; Johan Monbaliu; Paul Fleming; Lawrence Dick; Mark Manfredi; Christopher Claiborne; Joseph Bolen; Erik Kupperman; Allison Berger
Journal:  Cancer Chemother Pharmacol       Date:  2011-03-13       Impact factor: 3.333

10.  Patient decision-making about complementary and alternative medicine in cancer management: context and process.

Authors:  L G Balneaves; L Weeks; D Seely
Journal:  Curr Oncol       Date:  2008-08       Impact factor: 3.677

View more
  1 in total

Review 1.  Addressing Complementary and Alternative Medicine Use Among Individuals With Cancer: An Integrative Review and Clinical Practice Guideline.

Authors:  Lynda G Balneaves; Cody Z Watling; Emilie N Hayward; Brenda Ross; Jill Taylor-Brown; Antony Porcino; Tracy L O Truant
Journal:  J Natl Cancer Inst       Date:  2022-01-11       Impact factor: 13.506

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.